Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Antiviral treatments strive to block a virus or halt its replication ... reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...